Kwb Wealth Lexicon Pharmaceuticals, Inc. Transaction History
Kwb Wealth
- $806 Million
- Q3 2024
A detailed history of Kwb Wealth transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Kwb Wealth holds 40,640 shares of LXRX stock, worth $32,918. This represents 0.01% of its overall portfolio holdings.
Number of Shares
40,640
Previous 40,640
-0.0%
Holding current value
$32,918
Previous $68,000
7.35%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding LXRX
# of Institutions
141Shares Held
238MCall Options Held
459KPut Options Held
133K-
Artal Group S.A. Luxembourg, N4136MShares$110 Million100.0% of portfolio
-
Siren, L.L.C. New York, NY38.9MShares$31.5 Million3.05% of portfolio
-
Orbimed Advisors LLC San Diego, CA11MShares$8.93 Million0.41% of portfolio
-
Black Rock Inc. New York, NY9.89MShares$8.01 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.09MShares$6.55 Million0.0% of portfolio
About LEXICON PHARMACEUTICALS, INC.
- Ticker LXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 188,726,000
- Market Cap $153M
- Description
- Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...